Publications
Publications 5776 - 5800 de 33557
| Titre | DOI |
|---|---|
|
Circulating tumor cells (CTC) and endothelial cells (CEC) prognostic value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: First results of a prospective cohort from the French Breast Cancer In J.Y. Pierga; O. Tredant; M. Chevrier; C. Dubot; V. Lorgis; G. Romieu; A. Goncalves; M. Debled; C. Levy; J.M. Ferrero; C. Jouannaud; E. Luporsi; M.A. Mouret-Reynier; F. Dalenc; F. Berger; J. Lemonnier; C. Proudhon; F.C. Bidard 2017 |
10.1158/1538-7445.SABCS16-P1-01-02 |
|
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial F.C. Bidard; N. Kiavue; M. Ychou; L. Cabel; M.H. Stern; J. Madic; A. Saliou; A. Rampanou; C. Decraene; O. Bouche; M. Rivoire; F. Ghiringhelli; E. Francois; R. Guimbaud; L. Mineur; F. Khemissa-Akouz; T. Mazard; D. Moussata; C. Proudhon; J.Y. Pierga; T. Stanbury; S. Thezenas; P. Mariani 2019 |
10.3390/cells8060516 |
|
Circulating tumor cells as a tool to guide first line therapy in metastatic breast cancer: subgroup analyses of the STIC CTC Phase III utility trial F.C. Bidard; W. Jacot; S. Dureau; E. Brain; T. Bachelot; H. Bourgeois; A. Goncalves; S. Ladoire; H. Naman; F. Dalenc; J. Gligorov; M. Espie; C. Levy; J.M. Ferrero; D. Loirat; P. Cottu; V. Dieras; M.E. Legrier; F. Berger; C. Alix-Panabieres; J.Y. Pierga 2019 |
10.1158/1538-7445.AM2019-CT140 |
|
Circulating tumor cells as prognostic marker in ovarian carcinoma: Results from the ANTHALYA study D.La Motte Rouge; P. Cottu; P. Pautier; M. Provansal; A. Floquet; F. Selle; M. Fabbro; E. Kalbacher; P. Follana; A.F. Lesoin; J. Medioni; J. Dupin; R.M. Ferri; F.C. Bidard; C. Dubot; R. Rouzier; J. Lobbedez 2017 |
|
|
Circulating tumor cells kinetics in ovarian carcinoma: correlation with baseline characteristics and CA-125 levels in the randomized ANTHALYA trial evaluating bevacizumab in the neoadjuvant setting P. Cottu; D.La Motte Rouge; P. Pautier; M. Provansal; A. Floquet; F. Selle; M.A. Mouret-Reynier; M. Fabbro; E. Kalbacher; C. Piprot; P. Follana; A. Lesoin; J. Medioni; V. Menguy; Y. Ghazi; F.C. Bidard; C. Dubot; F. Joly 2015 |
10.1016/S0959-8049(16)31538-6 |
|
Circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) predictive value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: Results of a prospective cohort from the French Breast Cancer In J.Y. Pierga; A. Silveira; V. Lorgis; M.L. Tanguy; O. Tredan; C. Dubot; W. Jacot; A. Goncalves; M. Debled; C. Levy; J.M. Ferrero; C. Jouannaud; E. Luporsi; M.A. Mouret-Reynier; F. Dalenc; J. Lemonnier; F. Berger; C. Proudon; F.C. Bidard 2019 |
10.1158/1538-7445.SABCS18-PD2-03 |
|
Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF plus Non-Small Cell Lung Cancer S. Ortiz-Cuaran; L. Mezquita; A. Swalduz; M. Aldea; J. Mazieres; C. Jovelet; W.R.Chumbi Flores; L. Lacroix; Y. Loriot; L. Friboulet; V. Westeel; M. Ngocamus; A. Pradines; C. Tissot; C. Duchene; C. Raynaud; X. Quantin; R. Gervais; E. Brain; I. Monnet; G. Leprieur; V. Avrillon; M.A. Oukhatar; N. Hoog-Labouret; F. De Kievit; K. Howarth; J. Guichou; C. Morris; E. Green; M. Perol; B. Besse; J. Blay; P. Saintigny; D. Planchard 2019 |
10.1016/j.jtho.2019.08.678 |
|
Circulating tumor DNA and circulating tumor cells as predictor of outcome in the PRODIGE14-ACCORD21-METHEP2 phase II trial F.C. Bidard; M. Ychou; J. Madic; A. Saliou; O. Bouche; M. Rivoire; F. Ghiringhelli; E. Francois; R. Guimbaud; L. Mineur; F. Khemissa-Akouz; T. Mazard; D. Moussata; W. Cacheux; C. Proudhon; M.H. Stern; J.Y. Pierga; T. Stanbury; S. Thezenas; P. Mariani 2016 |
10.1093/annonc/mdw370.5 |
|
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer S. Ortiz-Cuaran; L. Mezquita; A. Swalduz; M. Aldea; J. Mazieres; C. Leonce; C. Jovelet; A. Pradines; V. Avrillon; W.R.Chumbi Flores; L. Lacroix; Y. Loriot; V. Westeel; M. Ngo-Camus; C. Tissot; C. Raynaud; R. Gervais; E. Brain; I. Monnet; E.Giroux Leprieur; C. Caramella; C.MahierAit Oukhatar; N. Hoog-Labouret; F. de Kievit; K. Howarth; C. Morris; E. Green; L. Friboulet; S. Chabaud; J.F. Guichou; M. Perol; B. Besse; J.Y. Blay; P. Saintigny; D. Planchard 2020 |
10.1158/1078-0432.CCR-20-1037 |
|
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma D.M. Kurtz; F. Scherer; M.C. Jin; J. Soo; A.F.M. Craig; M.Shahrokh Esfahani; J.J. Chabon; H. Stehr; C.Long Liu; R. Tibshirani; L.S. Maeda; N.K. Gupta; M.S. Khodadoust; R.H. Advani; R. Levy; A.M. Newman; U. Duehrsen; A. Huettmann; M. Meignan; R.O. Casasnovas; J.R. Westin; M. Roschewski; W.H. Wilson; G. Gaidano; D. Rossi; M. Diehn; A.A. Alizadeh 2018 |
10.1200/JCO.2018.78.5246 |
|
Circumcision and Risk of Febrile Urinary Tract Infection in Boys with Posterior Urethral Valves: Result of the CIRCUP Randomized Trial L. Harper; T. Blanc; M. Peycelon; J.L. Michel; M.D. Leclair; S. Garnier; V. Flaum; A.P. Arnaud; T. Merrot; E. Dobremez; A. Faure; L. Fourcade; M.L. Poli-Merol; Y. Chaussy; O. Dunand; F. Collin; L. Huiart; C. Ferdynus; F. Sauvat 2022 |
10.1016/j.eururo.2021.08.024 |
|
Circumscribed myositis ossificans D. Wendling; M. Chouk; X. Guillot; S. Aubry; C. Prati 2021 |
10.1016/j.jbspin.2020.105119 |
|
Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: A large multicentre audit with real-life results D. Thabut; A. Pauwels; N. Carbonell; A.Jean Remy; P. Nahon; X. Causse; J.P. Cervoni; J.F. Cadranel; I. Archambeaud; S. Bramli; F. Ehrhard; P. Ah-Soune; F. Rostain; A. Pariente; J. Vergniol; J.P. Dupuychaffray; A.L. Pelletier; F. Skinazi; A. Guillygomarc'h; R.L. Vitte; J. Henrion; S. Combet; M. Rudler; C. Bureau; C.Francophon Hypertension; A. Hepato-Gastroenterologues 2018 |
|
|
Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma B. Vanbervliet-Defrance; T. Delaunay; T. Daunizeau; V. Kepenekian; O. Glehen; K. Weber; Y. Estornes; A. Ziverec; L. Djemal; M. Delphin; S. Lantuejoul; G. Passot; M. Gregoire; O. Micheau; C. Blanquart; T. Renno; J.F. Fonteneau; S. Lebecque; K. Mahtouk 2020 |
10.1016/j.canlet.2019.12.016 |
|
Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood J. Boustani; E.Lauret Mar Joseph; E. Martin; S. Benhmida; B. Lecoester; F. Tochet; C. Mirjolet; C. Chevalier; D. Thibouw; N. Vulquin; S. Servagi; X. Sun; O. Adotevi 2021 |
10.1186/s12865-021-00429-5 |
|
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review F. Fiteni; T. Nguyen; D. Vernerey; M.J. Paillard; S. Kim; M. Demarchi; F. Fein; C. Borg; F. Bonnetain; X. Pivot 2014 |
10.1002/cam4.299 |
|
Cistercians and the transmission of texts (XIII-XVIII centuries) C. Rey 2019 |
|
|
Cistercians and the transmission of texts (XIII-XVIII centuries) C. Rey 2019 |
|
|
Citizen Participation and Political Communication in a Digital World Introduction A. Frame 2016 |
|
|
Citizen Participation and Political Communication in a Digital World Introduction A. Frame 2016 |
|
|
CITIZENSHIP, UNIVERSALISM AND STOIC COSMOPOLITANISM: THE ROMAN CASE A. Gonzales 2018 |
10.20318/ARYS.2018.4557 |
|
City size and the risk of being unemployed. Job pooling vs. job competition C. Gaigne; M. Sanch-Maritan 2019 |
10.1016/j.regsciurbeco.2019.05.002 |
|
City-Product Service System: a Multi-scale Intelligent Engineering Design Approach Z. Zhang; E. Ostrosi; A.J. Fougeres; J.B. Bluntzer; Y. Liu; F. Pfaender; M.Z. Tzen 2014 |
10.3233/978-1-61499-440-4-405 |
|
Claiming the sea: Bronze Age fortified sites of the north-eastern Adriatic Sea (Cres and Loinj islands, Croatia) Z. Cuckovic 2017 |
10.1080/00438243.2017.1341331 |
|
Clarkson-McCarthy inequalities with unitary and isometry orbits J.C. Bourin; E.Y. Lee 2020 |
10.1016/j.laa.2020.04.019 |